Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 5
2005 7
2006 5
2007 11
2008 9
2009 13
2010 10
2011 16
2012 11
2013 26
2014 11
2015 16
2016 19
2017 20
2018 24
2019 21
2020 21
2021 30
2022 22
2023 11
2024 21
2025 20
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

320 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean min jung lee (424 results)?
Systematic Profiling of DNMT3A Variants Reveals Protein Instability Mediated by the DCAF8 E3 Ubiquitin Ligase Adaptor.
Huang YH, Chen CW, Sundaramurthy V, Słabicki M, Hao D, Watson CJ, Tovy A, Reyes JM, Dakhova O, Crovetti BR, Galonska C, Lee M, Brunetti L, Zhou Y, Tatton-Brown K, Huang Y, Cheng X, Meissner A, Valk PJM, Van Maldergem L, Sanders MA, Blundell JR, Li W, Ebert BL, Goodell MA. Huang YH, et al. Among authors: lee m. Cancer Discov. 2022 Jan;12(1):220-235. doi: 10.1158/2159-8290.CD-21-0560. Epub 2021 Aug 24. Cancer Discov. 2022. PMID: 34429321 Free PMC article.
NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING.
Kim YS, Nabet BY, Cortez BN, Sun NY, Sebastian R, Redon CE, Ray A, Liu L, Ishola AA, Loew S, Dhall A, Sindiri S, Gayevskiy V, Lee MJ, Rastogi S, Sato N, Kedei N, Andresson T, Das S, Kumar S, Bers AE, Zhang H, Chiappori A, Gopal P, Abazeed ME, Chen H, Aladjem MI, Pommier Y, Velez MJ, Shames DS, Roper N. Kim YS, et al. J Clin Invest. 2025 Jul 8;135(18):e185423. doi: 10.1172/JCI185423. eCollection 2025 Sep 16. J Clin Invest. 2025. PMID: 40627448 Free PMC article. Clinical Trial.
Senescence-accelerated mice prone 8 (SAMP8) in male as a spontaneous osteoarthritis model.
Sanada Y, Ikuta Y, Ding C, Shinohara M, Yimiti D, Ishitobi H, Nagira K, Lee M, Akimoto T, Shibata S, Ishikawa M, Nakasa T, Matsubara K, Lotz MK, Adachi N, Miyaki S. Sanada Y, et al. Among authors: lee m. Arthritis Res Ther. 2022 Oct 18;24(1):235. doi: 10.1186/s13075-022-02916-5. Arthritis Res Ther. 2022. PMID: 36258202 Free PMC article.
Topoisomerase III-beta protects from immune dysregulation and tumorigenesis.
Al Mahmud MR, Baechler SA, Dhall A, Saha S, Zhang H, Bassel L, Zhang S, Lee MJ, Sato N, Rastogi S, Kumar S, Alam MS, Saha LK, Mock BA, Factor VM, Pommier Y. Al Mahmud MR, et al. Sci Adv. 2025 Dec 19;11(51):eady7028. doi: 10.1126/sciadv.ady7028. Epub 2025 Dec 19. Sci Adv. 2025. PMID: 41417894 Free PMC article.
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.
Abel ML, Takahashi N, Peer C, Redon CE, Nichols S, Vilimas R, Lee MJ, Lee S, Shelat M, Kattappuram R, Sciuto L, Pinkiert D, Graham C, Butcher D, Karim B, Sharma AK, Malin J, Kumar R, Schultz CW, Goyal S, Del Rivero J, Krishnamurthy M, Upadhyay D, Schroeder B, Sissung T, Tyagi M, Kim J, Pommier Y, Aladjem M, Raffeld M, Figg WD, Trepel J, Xi L, Desai P, Thomas A. Abel ML, et al. Clin Cancer Res. 2023 Sep 15;29(18):3603-3611. doi: 10.1158/1078-0432.CCR-23-0536. Clin Cancer Res. 2023. PMID: 37227187 Free PMC article.
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.
Apolo AB, Girardi DM, Niglio SA, Nadal R, Kydd AR, Simon N, Ley L, Cordes LM, Chandran E, Steinberg SM, Lee S, Lee MJ, Rastogi S, Sato N, Cao L, Banday AR, Boudjadi S, Merino MJ, Toubaji A, Akbulut D, Redd B, Bagheri H, Costello R, Gurram S, Agarwal PK, Chalfin HJ, Valera V, Streicher H, Wright JJ, Sharon E, Figg WD, Parnes HL, Gulley JL, Saraiya B, Pal SK, Quinn D, Stein MN, Lara PN, Bottaro DP, Mortazavi A. Apolo AB, et al. J Clin Oncol. 2024 Sep 1;42(25):3033-3046. doi: 10.1200/JCO.23.02233. Epub 2024 Jul 2. J Clin Oncol. 2024. PMID: 38954785 Free PMC article. Clinical Trial.
Topoisomerase IIIβ protects from tumorigenesis and immune dysregulation.
Al Mahmud MR, Baechler SA, Dhall A, Saha S, Zhang H, Zhang S, Lee MJ, Sato N, Rastogi S, Kumar S, Alam MS, Saha LK, Mock BA, Factor VM, Pommier Y. Al Mahmud MR, et al. bioRxiv [Preprint]. 2025 Mar 15:2025.03.13.643061. doi: 10.1101/2025.03.13.643061. bioRxiv. 2025. PMID: 40568167 Free PMC article. Preprint.
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial.
Giudice E, Huang TT, Nair JR, Zurcher G, McCoy A, Nousome D, Radke MR, Swisher EM, Lipkowitz S, Ibanez K, Donohue D, Malys T, Lee MJ, Redd B, Levy E, Rastogi S, Sato N, Trepel JB, Lee JM. Giudice E, et al. Nat Commun. 2024 Mar 30;15(1):2805. doi: 10.1038/s41467-024-47215-6. Nat Commun. 2024. PMID: 38555285 Free PMC article. Clinical Trial.
320 results